EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction

European Urology

Volumn 67, Issue 6, 2015, Pages 1099-1109

  Gratzke, Christian ^a   Bachmann, Alexander ^b   Descazeaud, Aurelien ^c   Drake, Marcus J ^d   Madersbacher, Stephan ^e   Mamoulakis, Charalampos ^f   Oelke, Matthias ^g   Tikkinen, Kari A O ^h   Gravas, Stavros ⁱ  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF LIMOGES   (France)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e KAISER FRANZ JOSEF HOSPITAL   (Austria)

^f UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^g HANNOVER MEDICAL SCHOOL   (Germany)

^h HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁱ UNIVERSITY OF THESSALY   (Greece)

Author keywords

Benign prostatic hyperplasia; Bladder outlet obstruction; Clinical practice guidelines; Detrusor overactivity; Diagnosis; Lower urinary tract symptoms; Nocturia; Nocturnal polyuria; Overactive bladder

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BENIGN PROSTATIC OBSTRUCTION; CLINICAL ASSESSMENT; CONSENSUS; CYSTOSCOPY; DELPHI STUDY; EVIDENCE BASED PRACTICE; HEMATURIA; HUMAN; HYDRONEPHROSIS; KIDNEY DISEASE; LOWER URINARY TRACT SYMPTOM; MEDICAL DECISION MAKING; MEDICAL HISTORY; MEDICAL LITERATURE; MICTURITION; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; POSTVOID RESIDUAL URINE VOLUME; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; URINALYSIS; UROFLOWMETRY; UROLITHIASIS; VALIDATION PROCESS; ADULT; AGED; BLOOD; COMPLICATION; DIFFERENTIAL DIAGNOSIS; EUROPE; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSTATE; PROSTATIC HYPERPLASIA; STANDARDS; URINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CYSTOSCOPY; DIAGNOSIS, DIFFERENTIAL; EUROPE; EVIDENCE-BASED PRACTICE; GUIDELINES AS TOPIC; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; URINALYSIS;

EID: 84929026223     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.12.038     Document Type: Review

References (97)

1. S.A. Martin, M.T. Haren, V.R. Marshall, K. Lange, and G.A. Wittert Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men World J Urol 29 2011 179 184
2. V. Kupelian, J.T. Wei, and M.P. O'Leary Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey Arch Intern Med 166 2006 2381 2387
3. D.A. Taub, and J.T. Wei The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States Curr Urol Rep 7 2006 272 281
4. P. Abrams, L. Cardozo, and M. Fall The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society Neurourol Urodyn 21 2002 167 178
5. Phillips B, Ball C, Sackett D, et al. Oxford Centre for Evidence-based Medicine - levels of evidence (March 2009). Centre for Evidence-Based Medicine Web site. http://www.cebm.net/index.aspx?o=1025. Accessed February 2014.
6. G. Novara, A. Galfano, M. Gardi, V. Ficarra, L. Boccon-Gibod, and W. Artibani Critical review of guidelines for BPH diagnosis and treatment strategy Eur Urol Suppl 4 2006 418 429
7. J. Irani, C.T. Brown, J. van der Meulen, and M. Emberton A review of guidelines on benign prostatic hyperplasia and lower urinary tract symptoms: are all guidelines the same? BJU Int 92 2003 937 942
8. K.T. McVary, C.G. Roehrborn, and A.L. Avins Update on AUA guideline on the management of benign prostatic hyperplasia J Urol 185 2011 1793 1803
9. J. Bosch, P. Abrams, and N. Cotterill Etiology, patient assessment and predicting outcome from therapy C. Chapple, P. Abrams, Male lower urinary tract symptoms 2013 International Consultation on Urological Diseases Male LUTS Guideline Montreal, Canada 37 133
10. J.M. Young, D.J. Muscatello, and J.E. Ward Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence BJU Int 85 2000 1037 1048
11. R.M. Martin, L. Vatten, D. Gunnell, P. Romundstad, and T.I. Nilsen Lower urinary tract symptoms and risk of prostate cancer: the HUNT 2 Cohort, Norway Int J Cancer 123 2008 1924 1928
12. A.B. Barqawi, K.F. Sullivan, and E.D. Crawford Methods of developing UWIN, the modified American Urological Association symptom score J Urol 186 2011 940 944
13. J. Schou, A.L. Poulsen, and J. Nordling The value of a new symptom score (DAN-PSS) in diagnosing uro-dynamic infravesical obstruction in BPH Scand J Urol Nephrol 27 1993 489 492
14. M.J. Barry, F.J. Fowler Jr., and M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association J Urol 148 1992 1549 1557
15. J.L. Donovan, T.J. Peters, P. Abrams, S.T. Brookes, J.J. de aa Rosette, and W. Schafer Scoring the short form ICSmaleSF questionnaire. International Continence Society J Urol 164 2000 1948 1955
16. Y. Homma, M. Yoshida, and N. Seki Symptom assessment tool for overactive bladder syndrome - overactive bladder symptom score Urology 68 2006 318 323
17. Y. Homma, M. Yoshida, T. Yamanishi, and M. Gotoh Core Lower Urinary Tract Symptom score (CLSS) questionnaire: a reliable tool in the overall assessment of lower urinary tract symptoms Int J Urol 15 2008 816 820
18. R.S. Epstein, P.A. Deverka, and C.G. Chute Validation of a new quality of life questionnaire for benign prostatic hyperplasia J Clin Epidemiol 45 1992 1431 1445
19. J.N. Cornu, P. Abrams, and C.R. Chapple A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management - a systematic review and meta-analysis Eur Urol 62 2012 877 890
20. J.P. Weiss Nocturia: "do the math" J Urol 175 2006 S16 S18
21. J.P. Weiss, J.L. Ruud Bosch, and M. Drake Nocturia think tank: focus on nocturnal polyuria: ICI-RS 2011 Neurourol Urodyn 31 2012 330 339
22. M.H. Blanker, A.M. Bohnen, F.P. Groeneveld, R.M. Bernsen, A. Prins, and J.L. Ruud Bosch Normal voiding patterns and determinants of increased diurnal and nocturnal voiding frequency in elderly men J Urol 164 2000 1201 1205
23. E.P. van Haarst, J.L. Bosch, and E.A. Heldeweg The International Prostate Symptom Score overestimates nocturia assessed by frequency-volume charts J Urol 188 2012 211 215
24. C.P. Vaughan, T.M. Johnson II, P.S. Goode, D.T. Redden, K.L. Burgio, and A.D. Markland Military exposure and urinary incontinence among American men J Urol 191 2014 125 129
25. E. Bright, M.J. Drake, and P. Abrams Urinary diaries: evidence for the development and validation of diary content, format, and duration Neurourol Urodyn 30 2011 348 352
26. J.S. Brown, K.S. McNaughton, and J.F. Wyman Measurement characteristics of a voiding diary for use by men and women with overactive bladder Urology 61 2003 802 809
27. D. Gordon, and A. Groutz Evaluation of female lower urinary tract symptoms: overview and update Curr Opin Obstet Gynecol 13 2001 521 527
28. Y. Homma, T. Ando, and M. Yoshida Voiding and incontinence frequencies: variability of diary data and required diary length Neurourol Urodyn 21 2002 204 209
29. J.H. Ku, I.G. Jeong, D.J. Lim, S.S. Byun, J.S. Paick, and S.J. Oh Voiding diary for the evaluation of urinary incontinence and lower urinary tract symptoms: prospective assessment of patient compliance and burden Neurourol Urodyn 23 2004 331 335
30. J.L. Locher, P.S. Goode, D.L. Roth, R.L. Worrell, and K.L. Burgio Reliability assessment of the bladder diary for urinary incontinence in older women J Gerontol A Biol Sci Med Sci 56 2001 M32 M35
31. I. Nygaard, and R. Holcomb Reproducibility of the seven-day voiding diary in women with stress urinary incontinence Int Urogynecol J Pelvic Floor Dysfunct 11 2000 15 17
32. T.L. Yap, D.C. Cromwell, and M. Emberton A systematic review of the reliability of frequency-volume charts in urological research and its implications for the optimum chart duration BJU Int 99 2007 9 16
33. E. Bright, N. Cotterill, M. Drake, and P. Abrams Developing a validated urinary diary: phase 1 Neurourol Urodyn 31 2012 625 633
34. J.L. Bosch, A.M. Bohnen, and F.P. Groeneveld Validity of digital rectal examination and serum prostate specific antigen in the estimation of prostate volume in community-based men aged 50 to 78 years: the Krimpen Study Eur Urol 46 2004 753 759
35. M. Oelke, A. Bachmann, and A. Descazeaud EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction Eur Urol 64 2013 118 140
36. J. Palou, D. Wood, and B.H. Bochner ICUD-EAU International Consultation on Bladder Cancer 2012: urothelial carcinoma of the prostate Eur Urol 63 2013 81 87
37. M. Roupret, M. Babjuk, and E. Comperat European guidelines on upper tract urothelial carcinomas: 2013 update Eur Urol 63 2013 1059 1071
38. M. Burger, W. Oosterlinck, and B. Konety ICUD-EAU International Consultation on Bladder Cancer 2012: non-muscle-invasive urothelial carcinoma of the bladder Eur Urol 63 2013 36 44
39. Grabe M, Bjerklund-Johansen TE, Botto H, et al. Guidelines on urological infections. European Association of Urology; 2013. http://www.uroweb.org
40. C.G. Roehrborn, G. Bartsch, and R. Kirby Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative, international overview Urology 58 2001 642 650
41. P. Abrams, C. Chapple, S. Khoury, C. Roehrborn, and J. de la Rosette Evaluation and treatment of lower urinary tract symptoms in older men J Urol 189 1 Suppl 2013 S93 S101
42. European Confederation of Laboratory Medicine European urinalysis guidelines Scand J Clin Lab Invest Suppl 231 2000 1 86
43. J.T. Wei, M.M. Miner, and W.D. Steers Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry J Urol 186 2011 971 976
44. R. Khasriya, S. Khan, and R. Lunawat The inadequacy of urinary dipstick and microscopy as surrogate markers of urinary tract infection in urological outpatients with lower urinary tract symptoms without acute frequency and dysuria J Urol 183 2010 1843 1847
45. T.A. Stamey, N. Yang, A.R. Hay, J.E. McNeal, F.S. Freiha, and E. Redwine Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 317 1987 909 916
46. C.G. Roehrborn, P. Boyle, A.L. Gould, and J. Waldstreicher Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia Urology 53 1999 581 589
47. A.M. Bohnen, F.P. Groeneveld, and J.L. Bosch Serum prostate-specific antigen as a predictor of prostate volume in the community: the Krimpen study Eur Urol 51 2007 1645 1652
48. C.A. Mochtar, L.A. Kiemeney, and M.M. van Riemsdijk Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia Eur Urol 44 2003 695 700
49. A. Heidenreich, P.J. Bastian, and J. Bellmunt EAU Guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent - update 2013 Eur Urol 65 2014 124 137
50. C.G. Roehrborn, J. McConnell, and J. Bonilla Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study J Urol 163 2000 13 20
51. C.G. Roehrborn, P. Boyle, and D. Bergner Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group Urology 54 1999 662 669
52. B. Djavan, Y.K. Fong, and M. Harik Longitudinal study of men with mild symptoms of bladder outlet obstruction treated with watchful waiting for four years Urology 64 2004 1144 1148
53. C.G. Roehrborn Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study BJU Int 97 2006 734 741
54. J.D. McConnell, C.G. Roehrborn, and O.M. Bautista The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia N Engl J Med 349 2003 2387 2398
55. M.Y. Kang, J.H. Ku, and S.J. Oh Non-invasive parameters predicting bladder outlet obstruction in Korean men with lower urinary tract symptoms J Korean Med Sci 25 2010 272 275
56. K.B. Lim, H. Ho, K.T. Foo, M.Y. Wong, and S. Fook-Chong Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of bladder outlet obstruction Int J Urol 13 2006 1509 1513
57. M. Oelke, R. Kirschner-Hermanns, N. Thiruchelvam, and J. Heesakkers Can we identify men who will have complications from benign prostatic obstruction (BPO)? ICI-RS 2011 Neurourol Urodyn 31 2012 322 326
58. G.S. Gerber, E.R. Goldfischer, T.G. Karrison, and G.T. Bales Serum creatinine measurements in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia Urology 49 1997 697 702
59. C.V. Comiter, M.P. Sullivan, R.S. Schacterle, L.H. Cohen, and S.V. Valla Urodynamic risk factors for renal dysfunction in men with obstructive and nonobstructive voiding dysfunction J Urol 158 1997 181 185
60. S.K. Hong, S.T. Lee, and S.J. Jeong Chronic kidney disease among men with lower urinary tract symptoms due to benign prostatic hyperplasia BJU Int 105 2010 1424 1428
61. J.H. Lee, H. Kwon, Y.W. Park, I.C. Cho, and S.K. Min Relationship of estimated glomerular filtration rate with lower urinary tract symptoms/benign prostatic hyperplasia measures in middle-aged men with moderate to severe lower urinary tract symptoms Urology 82 2013 1381 1385
62. M. Oelke, K. Hofner, U. Jonas, J.J. de la Rosette, D.T. Ubbink, and H. Wijkstra Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume Eur Urol 52 2007 827 834
63. W.K. Mebust, H.L. Holtgrewe, A.T. Cockett, and P.C. Peters Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients J Urol 141 1989 243 247
64. Asimakopoulos AD, De Nunzio C, Kocjancic E, Tubaro A, Rosier PF, Finazzi-Agro E. Measurement of post-void residual urine. Neurourol Urodyn. In press. http://dx.doi.org/10.1002/nau.22671
65. A.D. Rule, D.J. Jacobson, M.E. McGree, C.J. Girman, M.M. Lieber, and S.J. Jacobsen Longitudinal changes in post-void residual and voided volume among community dwelling men J Urol 174 2005 1317 1321
66. M.P. Sullivan, and S.V. Yalla Detrusor contractility and compliance characteristics in adult male patients with obstructive and nonobstructive voiding dysfunction J Urol 155 1996 1995 2000
67. C.A. Mochtar, L.A. Kiemeney, M.M. van Riemsdijk, M.P. Laguna, F.M. Debruyne, and J.J. de la Rosette Post-void residual urine volume is not a good predictor of the need for invasive therapy among patients with benign prostatic hyperplasia J Urol 175 2006 213 216
68. R. Kranse, and R. van Mastrigt Causes for variability in repeated pressure-flow measurements Urology 61 2003 930 934
69. J.B. Jorgensen, K.M. Jensen, and P. Mogensen Age-related variation in urinary flow variables and flow curve patterns in elderly males Br J Urol 69 1992 265 271
70. J.M. Reynard, Q. Yang, and J.L. Donovan The ICS-BPH study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction Br J Urol 82 1998 619 623
71. T. Idzenga, J.J. Pel, and R. van Mastrigt Accuracy of maximum flow rate for diagnosing bladder outlet obstruction can be estimated from the ICS nomogram Neurourol Urodyn 27 2008 97 98
72. M.B. Siroky, C.A. Olsson, and R.J. Krane The flow rate nomogram: I. Development J Urol 122 1979 665 668
73. M.B. Siroky, C.A. Olsson, and R.J. Krane The flow rate nomogram: II. Clinical correlation J Urol 123 1980 208 210
74. A. Thorpe, and D. Neal Benign prostatic hyperplasia Lancet 361 2003 1359 1367
75. G.D. Grossfeld, and F.V. Coakley Benign prostatic hyperplasia: clinical overview and value of diagnostic imaging Radiol Clin North Am 38 2000 31 47
76. A.G. Wilkinson, and S.R. Wild Is pre-operative imaging of the urinary tract worthwhile in the assessment of prostatism? Br J Urol 70 1992 53 57
77. W.F. Koch, K. Ezz el Din, M.J. de Wildt, F.M. Debruyne, and J.J. de la Rosette The outcome of renal ultrasound in the assessment of 556 consecutive patients with benign prostatic hyperplasia J Urol 155 1996 186 189
78. A.C. Loch, A. Bannowsky, and L. Baeurle Technical and anatomical essentials for transrectal ultrasound of the prostate World J Urol 25 2007 361 366
79. K.G. Stravodimos, A. Petrolekas, and T. Kapetanakis TRUS versus transabdominal ultrasound as a predictor of enucleated adenoma weight in patients with BPH: a tool for standard preoperative work-up? Int Urol Nephrol 41 2009 767 771
80. S.J. Chia, C.T. Heng, S.P. Chan, and K.T. Foo Correlation of intravesical prostatic protrusion with bladder outlet obstruction BJU Int 91 2003 371 374
81. Y.H. Tan, and K.T. Foo Intravesical prostatic protrusion predicts the outcome of a trial without catheter following acute urine retention J Urol 170 2003 2339 2341
82. P. Mariappan, D.J. Brown, and A.S. McNeill Intravesical prostatic protrusion is better than prostate volume in predicting the outcome of trial without catheter in white men presenting with acute urinary retention: a prospective clinical study J Urol 178 2007 573 577
83. M. Arnolds, and M. Oelke Positioning invasive versus noninvasive urodynamics in the assessment of bladder outlet obstruction Curr Opin Urol 19 2009 55 62
84. M. Oelke International Consultation on Incontinence-Research Society (ICI-RS) report on non-invasive urodynamics: the need of standardization of ultrasound bladder and detrusor wall thickness measurements to quantify bladder wall hypertrophy Neurourol Urodyn 29 2010 634 639
85. M. Kojima, E. Inui, A. Ochiai, Y. Naya, O. Ukimura, and H. Watanabe Ultrasonic estimation of bladder weight as a measure of bladder hypertrophy in men with infravesical obstruction: a preliminary report Urology 47 1996 942 947
86. M. Kojima, E. Inui, A. Ochiai, Y. Naya, O. Ukimura, and H. Watanabe Noninvasive quantitative estimation of infravesical obstruction using ultrasonic measurement of bladder weight J Urol 157 1997 476 479
87. I. Shoukry, J.G. Susset, M.M. Elhilali, and D. Dutartre Role of uroflowmetry in the assessment of lower urinary tract obstruction in adult males Br J Urol 47 1975 559 566
88. R.M. Anikwe Correlations between clinical findings and urinary flow rate in benign prostatic hypertrophy Int Surg 61 1976 392 394
89. K.E. el Din, L.A. Kiemeney, M.J. de Wildt, P.F. Rosier, F.M. Debruyne, and J.J. de la Rosette The correlation between bladder outlet obstruction and lower urinary tract symptoms as measured by the international Prostate Symptom Score J Urol 156 1996 1020 1025
90. H. Hashim, and P. Abrams Is the bladder a reliable witness for predicting detrusor overactivity? J Urol 175 2006 191 194
91. M.M. Oh, H. Choi, and M.G. Park Is there a correlation between the presence of idiopathic detrusor overactivity and the degree of bladder outlet obstruction? Urology 77 2011 167 170
92. M. Oelke, J. Baard, H. Wijkstra, J.J. de la Rosette, U. Jonas, and K. Hofner Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia Eur Urol 54 2008 419 426
93. A.W. Thomas, A. Cannon, E. Bartlett, J. Ellis-Jones, and P. Abrams The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up BJU Int 93 2004 745 750
94. S.J. Jeong, H.J. Kim, and Y.J. Lee Prevalence and clinical features of detrusor underactivity among elderly with lower urinary tract symptoms: a comparison between men and women Korean J Urol 53 2012 342 348
95. A.W. Thomas, A. Cannon, E. Bartlett, J. Ellis-Jones, and P. Abrams The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction J Urol 174 2005 1887 1891
96. S. Al-Hayek, A. Thomas, and P. Abrams Natural history of detrusor contractility - minimum ten-year urodynamic follow-up in men with bladder outlet obstruction and those with detrusor Scand J Urol Nephrol Suppl 215 2004 101 108
97. M. Stohrer, B. Blok, and D. Castro-Diaz EAU guidelines on neurogenic lower urinary tract dysfunction Eur Urol 56 2009 81 88